OPSUMIT® (macitentan) video library
Explore an informative video series around the professional and patient perspectives on PAH featuring Lindsay, a patient living with PAH who has been taking OPSUMIT® since 2013.
Individual patient experience may vary. OPSUMIT® has a 9-year long-term safety, tolerability, and survival open-label extension study in patients with PAH.1
Lindsay's path to a PAH specialist